North American white mitochondrial haplogroups in prostate and renal cancer

Journal of Urology

Volumn 175, Issue 2, 2006, Pages 468-473

  Booker, Lyra M ^a   Habermacher, Geoffrey M ^a   Jessie, Benjamin C ^a   Sun, Qi Carrie ^a   Baumann, Amanda K ^a   Amin, Mahul ^a   Lim, So Dug ^a   Fernandez Golarz, Carina ^a   Lyles, Robert H ^b   Brown, Michael D ^d   Marshall, Fray F ^a   Petros, John A ^a,c,e  

^a Department of Urology ^*  (United States)

^b School of Public Health   (United States)

^c EMORY UNIVERSITY   (United States)

^d MERCER UNIVERSITY   (United States)

^e EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

DNA, mitochondrial; European continental ancestry group; Prostatic neoplasms; Renal neoplasms; Risk

Indexed keywords

MITOCHONDRIAL DNA;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER RISK; CONTROLLED STUDY; GENOTYPE; HAPLOTYPE; HIGH RISK POPULATION; HUMAN; INHERITANCE; KIDNEY CANCER; MAJOR CLINICAL STUDY; MALE; MITOCHONDRION; NORTH AMERICA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSTATE CANCER; RISK ASSESSMENT; STATISTICAL ANALYSIS;

EID: 30344471873     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)00163-1     Document Type: Article

References (19)

1. Cancer Facts and Figures 2005. 2005 American Cancer Society Atlanta
2. O. Warburg On the origin of cancer cells Science 123 1956 309
3. N. Gao, M. Ding, J.Z. Zheng, Z. Zhang, S.S. Leonard, K.J. Liu Vanadate-induced expression of hypoxia-inducible factor 1 alpha and vascular endothelial growth factor through phosphatidylinositol 3-kinase/Akt pathway and reactive oxygen species J Biol Chem 277 2002 31963
4. D.C. Wallace, M.T. Lott, M.D. Brown, K. Kerstann Mitochondria and neuro-opthalmologic diseases C.R. Scriver A.L. Beaudet D. Valle W.S. Sly B. Childs K.W. Kinzler The Metabolic and Molecular Bases of Inherited Disease 8th ed. 2001 McGraw-Hill New York 2425 2491
5. B. Kalman, S. Li, D. Chatterjee, J. O'Connor, M.R. Voehl, M.D. Brown Large scale screening of the mitochondrial DNA reveals no pathogenic mutations but a haplotype associated with multiple sclerosis in Caucasians Acta Neurol Scand 99 1999 16
6. A. Torroni, K. Huoponen, P. Francalacci, M. Petrozzi, L. Morelli, R. Scozzari Classification of European mtDNAs from an analysis of three European populations Genetics 144 1996 1835
7. G. De Benedicits, G. Rose, G. Carrieri, M. De Luca, E. Falcone, G. Passarino Mitochondrial DNA inherited variants are associated with successful aging and longevity in humans FASEB J 13 1999 1532
8. E. Ruiz-Pesini, A.C. Lapena, C. Diez-Sanchez, A. Perez-Martos, J. Montoya, E. Alvarez Human mtDNA haplogroups associated with high or reduced spermatozoa motility Am J Hum Genet 67 2000 682
9. B. Kalman, F.D. Lublin, H. Alder Mitochondrial DNA mutations in multiple sclerosis Mult Scler 1 1995 32
10. S. Hofmann, R. Bezold, M. Jaksch, B. Obermaier-Kusser, S. Mertens, P. Kaufhold Wolfram (DIDMOAD) syndrome and Leber hereditary optic neuropathy (LHON) are associated with distinct mitochondrial DNA haplotypes Genomics 39 1997 8
11. K. Majamaa, S. Finnila, J. Turkka, I.E. Hassinen Mitochondrial DNA haplogroup U as a risk factor for occipital stroke in migraine Lancet 352 1998 455
12. G. Zsurka, J. Ormos, B. Ivanyi, S. Turi, E. Endreffy, M. Magyari Mitochondrial mutation as a probable causative factor in familial progressive tubulointerstitial nephritis Hum Genet 99 1997 484
13. M. Richards, H. Corte-Real, P. Forster, V. Macaulay, H. Wilkinson-Herbots, A. Demaine Paleolithic and neolithic lineages in the European mitochondrial gene pool Am J Hum Genet 59 1996 185
14. R.S. Greenberg, E.D. Rustin, W.S. Clark Risk of genitourinary malignancies after cancer of the prostate Cancer 61 1988 396
15. M. McCredie, G.L. Macfarlane, J. Stewart, M. Coates Second primary cancers following cancers of the kidney and prostate in New South Wales (Australia), 1972-91 Cancer Causes Control 7 1996 337
16. P.A.S. Johnstone, C.R. Powell, R. Riffenburgh, D.C. Rohde, C.J. Kane Second primary malignancies in T1-3N0 prostate cancer patients treated with radiation therapy with 10-year followup J Urol 159 1998 946
17. F. Rabbani, V.E. Reuter, J. Katz, P. Russo Second primary malignancies associated with renal cell carcinoma influence of histologic type Urology 56 2000 399
18. H. Gronberg, A. Bergh, J.E. Damber, M. Emanuelsson Cancer risk in families with hereditary prostate carcinoma Cancer 89 2000 1315
19. B.J. Eldon, E. Jonsson, J. Tomasson, L. Tryggvadottir, H. Tulinius Familial risk of prostate cancer in Iceland BJU Int 92 2003 915